Vision is one of the most crucial human senses, yet more than 300 million people worldwide are at risk of vision loss due to various retinal diseases. While recent advancements in retinal disease ...
The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.
Researchers have explored potential treatment that could bring unexpected relief to people living with severe vision loss.The breakthrough involves commonly used gel called HPMC which is normally ...
Vision is one of the most crucial human senses, yet over 300 million people worldwide are at risk of vision loss due to various retinal diseases. While recent advancements in retinal disease ...
A new approach to gene therapy for retinitis pigmentosa may help patients with advanced disease regain vision regardless of which genetic mutation is causing the condition. An optogenetic therapy ...
Scientists in the UK have successfully used gene therapy to restore some vision to legally blind children with an inherited retinal condition. All 11 children in the clinical trial saw improvements ...
An unorthodox treatment called near-infrared light therapy, which shines powerful near-infrared light at the brain through ...
Diseases that affect the retina, the light-sensitive layer at the back of the eye, are a significant cause of visual impairment and blindness. Gene therapy holds promise for treating some of these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results